Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Arendrup, M.C. Meletiadis, J. Zaragoza, O. Jørgensen, K.M. Marcos-Zambrano, L.J. Kanioura, L. Cuenca-Estrella, M. Mouton, J.W. Guinea, J."'
Objectives: Rezafungin (CD101) is a new long-acting echinocandin allowing weekly dosing, currently undergoing phase-II clinical trials for invasive candidiasis. The aim of this study was to assess rezafungin's in vitro activity against the most frequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a9fbe68ca2dfe41e6e6447e91c5764e3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106928
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106928